Form 8-K - Current report:
SEC Accession No. 0001193125-25-290474
Filing Date
2025-11-21
Accepted
2025-11-21 06:15:33
Documents
15
Period of Report
2025-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bcab-20251120.htm   iXBRL 8-K 82640
2 EX-5.1 bcab-ex5_1.htm EX-5.1 22439
3 EX-10.1 bcab-ex10_1.htm EX-10.1 447686
4 EX-10.2 bcab-ex10_2.htm EX-10.2 426464
5 GRAPHIC img125052188_0.jpg GRAPHIC 53784
6 GRAPHIC img266578755_0.jpg GRAPHIC 304886
  Complete submission text file 0001193125-25-290474.txt   1709308

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20251120.xsd EX-101.SCH 24997
18 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20251120_htm.xml XML 4516
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 251504543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)